OnKure Therapeutics Statistics
Total Valuation
OKUR has a market cap or net worth of $181.78 million. The enterprise value is -$9.92 million.
Important Dates
The next estimated earnings date is Tuesday, August 11, 2026, before market open.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OKUR has 40.40 million shares outstanding. The number of shares has increased by 101.92% in one year.
| Current Share Class | 40.40M |
| Shares Outstanding | 40.40M |
| Shares Change (YoY) | +101.92% |
| Shares Change (QoQ) | +0.57% |
| Owned by Insiders (%) | 10.55% |
| Owned by Institutions (%) | 31.63% |
| Float | 17.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 290.85 |
| PB Ratio | 0.99 |
| P/TBV Ratio | 0.99 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.78, with a Debt / Equity ratio of 0.00.
| Current Ratio | 13.78 |
| Quick Ratio | 13.41 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7,695.63 |
Financial Efficiency
Return on equity (ROE) is -42.73% and return on invested capital (ROIC) is -27.85%.
| Return on Equity (ROE) | -42.73% |
| Return on Assets (ROA) | -25.77% |
| Return on Invested Capital (ROIC) | -27.85% |
| Return on Capital Employed (ROCE) | -33.39% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.31M |
| Employee Count | 45 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +75.78% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +75.78% |
| 50-Day Moving Average | 4.27 |
| 200-Day Moving Average | 3.37 |
| Relative Strength Index (RSI) | 58.23 |
| Average Volume (20 Days) | 555,691 |
Short Selling Information
The latest short interest is 282,400, so 0.70% of the outstanding shares have been sold short.
| Short Interest | 282,400 |
| Short Previous Month | 234,931 |
| Short % of Shares Out | 0.70% |
| Short % of Float | 1.61% |
| Short Ratio (days to cover) | 0.94 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -61.57M |
| Pretax Income | -58.75M |
| Net Income | -58.75M |
| EBITDA | -61.13M |
| EBIT | -61.57M |
| Earnings Per Share (EPS) | -$4.33 |
Full Income StatementBalance Sheet
The company has $192.11 million in cash and $409,000 in debt, giving a net cash position of $191.70 million or $4.75 per share.
| Cash & Cash Equivalents | 192.11M |
| Total Debt | 409,000 |
| Net Cash | 191.70M |
| Net Cash Per Share | $4.75 |
| Equity (Book Value) | 184.35M |
| Book Value Per Share | 4.56 |
| Working Capital | 183.15M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$50.76 million and capital expenditures -$33,000, giving a free cash flow of -$50.79 million.
| Operating Cash Flow | -50.76M |
| Capital Expenditures | -33,000 |
| Depreciation & Amortization | 433,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -50.79M |
| FCF Per Share | -$1.26 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |